| |
|
HCC | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
| 3. | HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma |
| |
Hepatology. 2023 Mar 1;77(3):774-788. doi: 10.1002/hep.32692. Epub 2023 Feb 17.
Na Sun 1 2, Ceng Zhang 1 3, Yi-Te Lee 1, Benjamin V Tran 4, Jing Wang 1, Hyoyong Kim 1, Junseok Lee 1, Ryan Y Zhang 1, Jasmine J Wang 1 5, Junhui Hu 6, Zhicheng Zhang 6, Manaf S Alsudaney 7, Kuan-Chu Hou 1, Hubert Tang 1, Tiffany X Zhang 1, Icy Y Liang 1, Ziang Zhou 1, Mengxiang Chen 1, Angela Hsiao-Jiun Yeh 8, Wenyuan Li 9, Xianghong Jasmine Zhou 9, Helena R Chang 4, Steven-Huy B Han 8, Saeed Sadeghi 8, Richard S Finn 8, Sammy Saab 8, Ronald W Busuttil 4, Mazen Noureddin 7 10, Walid S Ayoub 7 10, Alexander Kuo 7 10, Vinay Sundaram 7 10, Buraq Al-Ghaieb 7 10, Juvelyn Palomique 7, Kambiz Kosari 7, Irene K Kim 7, Tsuyoshi Todo 7, Nicholas N Nissen 7, Maria Lauda Tomasi 10, Sungyong You 11, Edwin M Posadas 5, James X Wu 4, Madhuri Wadehra 9, Myung-Shin Sim 12, Yunfeng Li 9, Hanlin L Wang 9, Samuel W French 9, Shelly C Lu 10 13, Lily Wu 6, Renjun Pei 2, Li Liang 14 15, Ju Dong Yang 7 10 13, Vatche G Agopian 4 16, Hsian-Rong Tseng 1 16, Yazhen Zhu 1 9 16
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 11. | Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database |
| |
Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21.
Alessandro Vitale # 1, Gianluca Svegliati-Baroni # 2 3, Alessio Ortolani 4, Monica Cucco 5 6, Giulio V Dalla Riva 7, Edoardo G Giannini 8, Fabio Piscaglia 9, Gianludovico Rapaccini 10, Mariella Di Marco 11, Eugenio Caturelli 12, Marco Zoli 13, Rodolfo Sacco 14, Giuseppe Cabibbo 15, Fabio Marra 16, Andrea Mega 17, Filomena Morisco 18, Antonio Gasbarrini 19, Francesco Giuseppe Foschi 20, Gabriele Missale 21, Alberto Masotto 22, Gerardo Nardone 23, Giovanni Raimondo 24, Francesco Azzaroli 25, Gianpaolo Vidili 26, Filippo Oliveri 27, Filippo Pelizzaro 1, Rafael Ramirez Morales 1, Umberto Cillo 1, Franco Trevisani 28, Luca Miele 29 30, Giulio Marchesini 31, Fabio Farinati 1; Italian Liver Cancer (ITA.LI.CA) group
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 19. | FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far? |
| |
Int J Mol Sci. 2023 Jan 31;24(3):2685. doi: 10.3390/ijms24032685.
Iason Psilopatis 1, Christos Damaskos 2 3, Anna Garmpi 4, Panagiotis Sarantis 5, Evangelos Koustas 5, Efstathios A Antoniou 3 6, Dimitrios Dimitroulis 6, Gregory Kouraklis 6, Michail V Karamouzis 5, Kleio Vrettou 7, Georgios Marinos 8, Konstantinos Kontzoglou 3 6, Nikolaos Garmpis 3 6
|
|
| |
|
|
| |
| 21. | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
| |
Gastroenterology Res. 2022 Dec;15(6):297-307. doi: 10.14740/gr1573.Epub 2022 Dec 1.
Robert J Wong 1, Channa Jayasekera 2, Patricia Jones 3, Fasiha Kanwal 4, Amit G Singal 5, Aijaz Ahmed 6, Robert Taglienti 7, Zobair Younossi 8, Laura Kulik 9, Neil Mehta 10
|
|
| |
|
|
| |
|
|
| |
| 24. | Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2 |
| |
Oncologist. 2022 Dec 9;27(12):e938-e948. doi: 10.1093/oncolo/oyac183.
Richard S Finn 1, Thomas Yau 2, Chih-Hung Hsu 3, Enrico N De Toni 4, Lipika Goyal 5, Peter R Galle 6, ShuKui Qin 7, Sujata Rao 8, Fangfang Sun 8, Chunxiao Wang 8, Ryan C Widau 8, Andrew X Zhu 9 10
|
|
| |
|
|
| |
|
|
| |
| 27. | A history of variceal bleeding is associated with further bleeding under atezolizumab-bevacizumab in patients with HCC |
| |
Liver Int. 2022 Dec;42(12):2843-2854. doi: 10.1111/liv.15458. Epub 2022 Oct 26.
Edouard Larrey 1, Bertille Campion 1, Manon Evain 1, Philippe Sultanik 1, Lorraine Blaise 2, Héloïse Giudicelli 1, Mathilde Wagner 3, Philippe Cluzel 4, Marika Rudler 1 5, Nathalie Ganne-Carrié 2 6, Dominique Thabut 1 5, Manon Allaire 1 6
|
|
| |
|
|
| |
| 29. | Surgical approach to microwave and radiofrequency liver ablation for hepatocellular carcinoma and colorectal liver metastases less than 5 cm: a systematic review and meta-analysis |
| |
Surg Endosc. 2022 Dec 21. doi: 10.1007/s00464-022-09815-5.Online ahead of print.
Moustafa Abdalla 1, Amelia T Collings 2, Rebecca Dirks 2, Edwin Onkendi 3, Daniel Nelson 4, Ahmad Ozair 5, Emily Miraflor 6, Faique Rahman 7, Jake Whiteside 2, Mihir M Shah 8, Subhashini Ayloo 9, Ahmed Abou-Setta 10, Iswanto Sucandy 11, Ali Kchaou 12, Samuel Douglas 13, Patricio Polanco 14, Timothy Vreeland 15, Joseph Buell 16, Mohammed T Ansari 17, Aurora D Pryor 18, Bethany J Slater 19, Ziad Awad 20, William Richardson 21, Adnan Alseidi 22, D Rohan Jeyarajah 23, Eugene Ceppa 24
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 36. | Pathogenesis to management of hepatocellular carcinoma |
| |
Genes Cancer. 2022 Dec 13;13:72-87. doi: 10.18632/genesandcancer.226.eCollection 2022.
Ben L Da 1, Kelly I Suchman 2, Lawrence Lau 3, Atoosa Rabiee 4, Aiwu Ruth He 5, Kirti Shetty 6, Herbert Yu 7, Linda L Wong 8, Richard L Amdur 9, James M Crawford 10, Sharon S Fox 10, Gregory M Grimaldi 11, Priya K Shah 11, Jonathan Weinstein 12, David Bernstein 1, Sanjaya K Satapathy 1, Nyasha Chambwe 13, Xiyan Xiang 14, Lopa Mishra 14
|
|
| |
|
|
| |
| 38. | Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study |
| |
J Nucl Med. 2022 Dec;63(12):1891-1898. doi: 10.2967/jnumed.122.263823.Epub 2022 May 19.
Margot T M Reinders 1, Karel J van Erpecum 2, Maarten L J Smits 3, Arthur J A T Braat 3, Joep de Bruijne 2, Rutger Bruijnen 3, Dave Sprengers 4, Robert A de Man 4, Erik Vegt 5, Jan N M IJzermans 6, Adriaan Moelker 5, Marnix G E H Lam 1
|
|
| |
| 39. | Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance |
| |
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2818-2825.e1.doi: 10.1016/j.cgh.2021.12.014. Epub 2021 Dec 10.
Amit G Singal 1, Sarah Reddy 2, Himani Radadiya Aka Patel 3, Deyaun Villarreal 3, Aisha Khan 4, Yan Liu 4, Vanessa Cerda 3, Nicole E Rich 2, Caitlin C Murphy 3, Jasmin A Tiro 3, Jennifer R Kramer 5, Ruben Hernaez 5
|
|
| |
| 40. | SIRT in 2025 |
| |
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1622-1633.doi: 10.1007/s00270-022-03228-6. Epub 2022 Aug 8.
Francesca Romana Ponziani # 1, Francesco Santopaolo # 1, Alessandro Posa 2, Maurizio Pompili 1 3, Alessandro Tanzilli 2, Marta Maestri 1, Maria Pallozzi 1, Francesca Ibba 1, Riccardo Manfredi 2 3, Antonio Gasbarrini # 1 3, Roberto Iezzi # 4 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 46. | Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review |
| |
Int J Mol Sci. 2022 Nov 15;23(22):14117. doi: 10.3390/ijms232214117.
Christos Damaskos 1 2, Nikolaos Garmpis 2 3, Dimitrios Dimitroulis 3, Anna Garmpi 4, Iason Psilopatis 5, Panagiotis Sarantis 6, Evangelos Koustas 6, Prodromos Kanavidis 7, Dionysios Prevezanos 1, Gregory Kouraklis 7, Michail V Karamouzis 6, Georgios Marinos 8, Konstantinos Kontzoglou 2 3, Efstathios A Antoniou 2 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 51. | Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360) |
| |
Curr Oncol. 2022 Nov 16;29(11):8802-8813. doi: 10.3390/curroncol29110692.
Tiziana Comito 1, Mauro Loi 2, Ciro Franzese 1 3, Elena Clerici 1, Davide Franceschini 1, Marco Badalamenti 1, Maria Ausilia Teriaca 1, Lorenza Rimassa 3 4, Vittorio Pedicini 5, Dario Poretti 5, Luigi Alessandro Solbiati 3 5, Guido Torzilli 3 6, Roberto Ceriani 7, Ana Lleo 3 7, Alessio Aghemo 3 7, Armando Santoro 3 4, Marta Scorsetti 1 3
|
|
| |
| 52. | Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis |
| |
ESMO Open. 2022 Oct 5;7(6):100591. doi: 10.1016/j.esmoop.2022.100591. Online ahead of print.
M Rimini 1, L Rimassa 2, K Ueshima 3, V Burgio 1, S Shigeo 4, T Tada 5, G Suda 6, C Yoo 7, J Cheon 8, D J Pinato 9, S Lonardi 10, M Scartozzi 11, M Iavarone 12, G G Di Costanzo 13, F Marra 14, C Soldà 15, E Tamburini 16, F Piscaglia 17, G Masi 18, G Cabibbo 19, F G Foschi 20, M Silletta 21, T Pressiani 22, N Nishida 3, H Iwamoto 4, N Sakamoto 6, B-Y Ryoo 7, H J Chon 8, F Claudia 9, T Niizeki 4, T Sho 6, B Kang 8, A D'Alessio 9, T Kumada 23, A Hiraoka 24, M Hirooka 25, K Kariyama 26, J Tani 27, M Atsukawa 28, K Takaguchi 29, E Itobayashi 30, S Fukunishi 31, K Tsuji 32, T Ishikawa 33, K Tajiri 34, H Ochi 35, S Yasuda 36, H Toyoda 36, C Ogawa 37, T Nishimur 38, T Hatanaka 39, S Kakizaki 40, N Shimada 41, K Kawata 42, T Tanaka 24, H Ohama 31, K Nouso 26, A Morishita 27, A Tsutsui 29, T Nagano 29, N Itokawa 28, T Okubo 28, T Arai 28, M Imai 33, A Naganuma 43, Y Koizumi 25, S Nakamura 5, K Joko 35, H Iijima 38, Y Hiasa 25, F Pedica 44, F De Cobelli 45, F Ratti 46, L Alrighetti 46, M Kudo 3, S Cascinu 47, A Casadei-Gardini 48
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 56. | Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review |
| |
J Clin Med. 2022 Oct 28;11(21):6368. doi: 10.3390/jcm11216368.
Alessandro Martinino 1, Mohammad Aloulou 2, Surobhi Chatterjee 3, Juan Pablo Scarano Pereira 4, Saurabh Singhal 5, Tapan Patel 6, Thomas Paul-Emile Kirchgesner 7, Salvatore Agnes 8, Salvatore Annunziata 9, Giorgio Treglia 10 11 12, Francesco Giovinazzo 8
|
|
| |
|
|
| |
|
|
| |
| 59. | Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future |
| |
Curr Oncol. 2022 Oct 8;29(10):7537-7551. doi: 10.3390/curroncol29100593.
Brianna Ruch 1, Josiah Wagler 1, Kayla Kumm 1, Chi Zhang 2 3, Nitin N Katariya 1, Mauricio Garcia-Saenz-de-Sicilia 4, Emmanouil Giorgakis 5, Amit K Mathur 1
|
|
| |
| 60. | Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial |
| |
J Gastroenterol Hepatol. 2015 Mar;30(3):559-65.doi: 10.1111/jgh.12791.
Giovan Giuseppe Di Costanzo 1, Raffaella Tortora, Giuseppe D'Adamo, Massimo De Luca, Filippo Lampasi, Luigi Addario, Alfonso Galeota Lanza, Francesco Paolo Picciotto, Maria Teresa Tartaglione, Gabriella Cordone, Michele Imparato, Silvana Mattera, Claudio Maurizio Pacella
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 65. | Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes |
| |
Cancers (Basel). 2022 Oct 18;14(20):5102. doi: 10.3390/cancers14205102.
Marcello Di Martino 1, Alessandro Vitale 2, Daniele Ferraro 1, Marilisa Maniscalco 1, Donatella Pisaniello 1, Giuseppe Arenga 1, Federica Falaschi 1, Alfonso Terrone 1, Alessandro Iacomino 1 2, Alfonso Galeota Lanza 3, Ciro Esposito 4, Umberto Cillo 2, Giovanni Vennarecci 1
|
|
| |
| 66. | Securing Wider EU Commitment to the Elimination of HCV |
| |
Liver Int. 2022 Oct 5. doi: 10.1111/liv.15446. Online ahead of print.
Heiner Wedemeyer 1, Tammo L Tergast 1, Jeffrey V Lazarus 2, Homie Razavi 3, Kostas Bakoyannis 4, Ricardo Baptista-Leite 5 6, Marco Bartoli 7, Philip Bruggmann 8, Cristian-Silviu Busoi 9, Maria Buti 10, Manuel Carballo 11, Laurent Castera 12, Massimo Colombo 13, Rodrigo Sousa Coutinho 14, Yuval Dadon 15, Gamal Esmat 16, Rafael Esteban 10, Joan Colom Farran 17, Mark Gillyon-Powell 18, David Goldberg 19, Sharon Hutchinson 20, Harry L A Janssen 21, George Kalamitsis 22, Loreta A Kondili 23, John S Lambert 24, Rui Tato Marinho 25, Mojca Maticic 26 27, Aldo Patricello 9, Markus Peck-Radosavljevic 28, Stanislas Pol 29, Mario Poljak 30, Cora Pop 31, Tomislov Sokol 9, Vana Sypsa 32, Nurdan Tözün 33, Zobair Younossi 34, Alessio Aghemo 35, George V Papatheodoridis 36, Angelos Hatzakis 32
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 75. | Early derangement of INR predicts liver failure after liver resection for hepatocellular carcinoma |
| |
Surgeon. 2022 Oct;20(5):e288-e295. doi: 10.1016/j.surge.2022.01.002.Epub 2022 Feb 7.
A N S Silva 1, M Greensmith 2, R K Praseedom 2, A Jah 2, E L Huguet 2, S J F Harper 2, S S Liau 2, B Basu 3, G J Alexander 4, R Brais 5, T C See 6, M Hoare 7, P Gibbs 2, A Balakrishnan 8
|
|
| |
|
|
| |
|
|
| |
| 78. | Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature |
| |
Hepatol Commun. 2022 Sep;6(9):2581-2593. doi: 10.1002/hep4.1991. Epub 2022 Jun 16.
Myung-Ho Kim 1, Mi-Young Kim 1 2 3, Shadi Salloum 1, Tongqi Qian 4, Lai Ping Wong 5 6, Min Xu 1, Yoojin Lee 1, Stuti G Shroff 7, Ruslan I Sadreyev 5 7, Kathleen E Corey 1, Thomas F Baumert 8 9, Yujin Hoshida 4, Raymond T Chung 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 84. | Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study |
| |
Cancer. 2022 Jul 15;128(14):2786-2795. doi: 10.1002/cncr.34256. Epub 2022 May 13.
Scott S Short 1, Zachary J Kastenberg 1, Guo Wei 1, Alex Bondoc 2, Roshni Dasgupta 2, Greg M Tiao 2, Erin Watters 2, Todd E Heaton 3, Dimitra Lotakis 3, Michael P La Quaglia 3, Andrew J Murphy 4, Andrew M Davidoff 4, Sara A Mansfield 4, Max R Langham 4, Timothy B Lautz 5, Riccardo A Superina 5, Katherine C Ott 5, Marcus M Malek 6, Katrina M Morgan 6, Eugene S Kim 7, Abigail Zamora 7, Danny Lascano 7, Jonathan Roach 8, Joseph T Murphy 9, David H Rothstein 10, Sanjeev A Vasudevan 11, Richard Whitlock 11, Dave R Lal 12, Brian Hallis 12, Andreana Bütter 13, Reto M Baertschiger 14, Eveline Lapidus-Krol 14, Juan Putra 15, Elisabeth R Tracy 16, Jennifer H Aldrink 17, Jordan Apfeld 17, Hau D Le 18, Keon Y Park 18, Barrie S Rich 19, Richard D Glick 19, Elizabeth A Fialkowski 20, Alan F Utria 20, Rebecka L Meyers 1, Kimberly J Riehle 10
|
|
| |
|
|
| |
| 86. | Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapies |
| |
Clin Cancer Res. 2022 Aug 15;28(16):3443-3451.doi: 10.1158/1078-0432.CCR-21-3135.
Masatoshi Kudo # 1, Robert Montal # 2 3, Richard S Finn 4, Florian Castet 3, Kazuomi Ueshima 1, Naoshi Nishida 1, Philipp K Haber 5, Youyou Hu 6, Yasutaka Chiba 7, Myron Schwartz 5, Tim Meyer 8 9, Riccardo Lencioni 10 11, Josep M Llovet 3 5 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 96. | Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial |
| |
J Cancer Res Clin Oncol. 2022 Sep;148(9):2487-2496.doi: 10.1007/s00432-021-03803-3. Epub 2021 Sep 20.
Osman Öcal # 1, Daniel Rössler # 2, Antonio Gasbarrini 3, Thomas Berg 4, Heinz-Josef Klümpen 5, Irene Bargellini 6, Bora Peynircioglu 7, Otto van Delden 8, Christian Schulz 2, Kerstin Schütte 9 10, Roberto Iezzi 11, Maciej Pech 12, Peter Malfertheiner 2, Bruno Sangro 13, Jens Ricke 1, Max Seidensticker 14
|
|
| |
| 97. | Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis |
| |
Clin Gastroenterol Hepatol. 2022 Aug 5;S1542-3565(22)00727-3.doi: 10.1016/j.cgh.2022.06.032. Online ahead of print.
Daniel Q Huang 1, Darren J H Tan 2, Cheng Han Ng 2, Maral Amangurbanova 3, Nancy Sutter 3, Phoebe Wen Lin Tay 2, Wen Hui Lim 2, Jie Ning Yong 2, Ansel Tang 2, Nicholas Syn 2, Mark D Muthiah 4, Eunice X X Tan 4, Shravan Dave 3, Benjamin Tay 5, Abdul M Majzoub 6, Danielle Gerberi 7, Beom Kyung Kim 8, Rohit Loomba 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 101. | Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival |
| |
Dig Liver Dis. 2022 Jul;54(7):927-936. doi: 10.1016/j.dld.2021.08.025. Epub 2021 Sep 25.
Filippo Pelizzaro 1, Giulia Peserico 2, Marco D'Elia 1, Nora Cazzagon 1, Francesco Paolo Russo 3, Alessandro Vitale 4, Edoardo G Giannini 5, Manuela Piccinnu 6, Gian Ludovico Rapaccini 7, Maria Di Marco 8, Eugenio Caturelli 9, Marco Zoli 10, Rodolfo Sacco 11, Giuseppe Cabibbo 12, Fabio Marra 13, Andrea Mega 14, Filomena Morisco 15, Antonio Gasbarrini 16, Gianluca Svegliati-Baroni 17, Francesco Giuseppe Foschi 18, Andrea Olivani 19, Alberto Masotto 20, Gerardo Nardone 21, Giovanni Raimondo 22, Francesco Azzaroli 23, Gianpaolo Vidili 24, Filippo Oliveri 25, Franco Trevisani 26, Fabio Farinati 27, Italian Liver Cancer (ITA.LI.CA) Study Group
|
|
| |
| 102. | Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation |
| |
JCI Insight. 2022 Jul 8;7(13):e159254. doi: 10.1172/jci.insight.159254.
Emilie Crouchet 1, Shen Li 2, Mozhdeh Sojoodi 2, Simonetta Bandiera 1, Naoto Fujiwara 3, Hussein El Saghire 1, Shijia Zhu 3, Tongqi Qian 3, Fahmida Akter Rasha 3, Fabio Del Zompo 1, Stephen C Barrett 2, Eugénie Schaeffer 1, Marine A Oudot 1, Clara Ponsolles 1, Sarah C Durand 1, Sarani Ghoshal 2, Gunisha Arora 2, Fabio Giannone 1 4 5, Raymond T Chung 6, Nevena Slovic 1, Nicolaas Van Renne 1, Emanuele Felli 1 4 5, Patrick Pessaux 1 4 5, Joachim Lupberger 1, Nathalie Pochet 7 8 9, Catherine Schuster 1, Kenneth K Tanabe 2, Yujin Hoshida 3, Bryan C Fuchs 2, Thomas F Baumert 1 4
|
|
| |
| 103. | Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis |
| |
Transpl Int. 2022 Jul 5;35:10175. doi: 10.3389/ti.2022.10175. eCollection 2022.
Ryan Lamm 1, Peter J Altshuler 1, Keyur Patel 1, Osama Shaheen 1, Angel Paulo Amante 1, Jesse Civan 2, Warren Maley 1, Adam Frank 1, Carlo Ramirez 1, Jaime Glorioso 1, Ashesh Shah 1, Hien Dang 1, Adam S Bodzin 1
|
|
| |
|
|
| |
| 105. | Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment |
| |
Nat Commun. 2022 Jul 8;13(1):3964. doi: 10.1038/s41467-022-31312-5.
Kai Markus Schneider # 1 2, Antje Mohs # 1, Wenfang Gui 1, Eric J C Galvez 3, Lena Susanna Candels 1, Lisa Hoenicke 3, Uthayakumar Muthukumarasamy 3, Christian H Holland 4 5, Carsten Elfers 1, Konrad Kilic 1, Carolin Victoria Schneider 1 6, Robert Schierwagen 7 8, Pavel Strnad 1, Theresa H Wirtz 1, Hanns-Ulrich Marschall 9, Eicke Latz 10 11 12, Benjamin Lelouvier 13, Julio Saez-Rodriguez 4 5, Willem de Vos 14 15, Till Strowig 3, Jonel Trebicka 7 8, Christian Trautwein 16
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 110. | Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases |
| |
Hepatology. 2022 Jul;76(1):251-274. doi: 10.1002/hep.32313. Epub 2022 Jan 22.
Marina Serper 1 2 3, Neehar D Parikh 4, Grace Thiele 1, Nadia Ovchinsky 5, Shivang Mehta 6, Alexander Kuo 7, Chanda Ho 8, Fasiha Kanwal 9 10 11, Michael Volk 12, Sumeet K Asrani 13, Marwan S Ghabril 14, John R Lake 15, Raphael B Merriman 16, Timothy R Morgan 17, Elliot B Tapper 4 18
|
|
| |
|
|
| |
| 112. | Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial |
| |
Lancet Oncol. 2022 Aug;23(8):995-1008.doi: 10.1016/S1470-2045(22)00326-6. Epub 2022 Jul 4.
Robin Kate Kelley 1, Lorenza Rimassa 2, Ann-Lii Cheng 3, Ahmed Kaseb 4, Shukui Qin 5, Andrew X Zhu 6, Stephen L Chan 7, Tamar Melkadze 8, Wattana Sukeepaisarnjaroen 9, Valery Breder 10, Gontran Verset 11, Edward Gane 12, Ivan Borbath 13, Jose David Gomez Rangel 14, Baek-Yeol Ryoo 15, Tamta Makharadze 16, Philippe Merle 17, Fawzi Benzaghou 18, Kamalika Banerjee 19, Saswati Hazra 19, Jonathan Fawcett 19, Thomas Yau 20
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 125. | HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis |
| |
J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023.Epub 2022 Feb 6.
Amit G Singal 1, Emily Zhang 2, Manasa Narasimman 2, Nicole E Rich 2, Akbar K Waljee 3, Yujin Hoshida 2, Ju Dong Yang 4, Maria Reig 5, Giuseppe Cabibbo 6, Pierre Nahon 7, Neehar D Parikh 3, Jorge A Marrero 8
|
|
| |
|
|
| |
| 127. | Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial |
| |
Clin Cancer Res. 2022 Jun 13;28(12):2547-2554.doi: 10.1158/1078-0432.CCR-21-3807
Gontran Verset 1, Ivan Borbath 2, Mark Karwal 3, Chris Verslype 4, Hans Van Vlierberghe 5, Adel Kardosh 6, Vittorina Zagonel 7, Per Stal 8, Debashis Sarker 9, Daniel H Palmer 10, Arndt Vogel 11, Julien Edeline 12, Stephane Cattan 13, Masatoshi Kudo 14, Ann-Lii Cheng 15, Sadahisa Ogasawara 16, Bruno Daniele 17, Stephen L Chan 18, Jennifer J Knox 19, Shukui Qin 20, Abby B Siegel 21, Michael Chisamore 21, Ken Hatogai 21, Anran Wang 21, Richard S Finn # 22, Andrew X Zhu # 23 24
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 139. | Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials |
| |
Clin Cancer Res. 2022 Jun 1;28(11):2297-2305.doi: 10.1158/1078-0432.CCR-21-4000.
Josep M Llovet 1 2 3, Amit G Singal 4, Augusto Villanueva 1, Richard S Finn 5, Masatoshi Kudo 6, Peter R Galle 7, Masafumi Ikeda 8, Sophie Callies 9, Louise M McGrath 9, Chunxiao Wang 9, Paolo Abada 9, Ryan C Widau 9, Elena Gonzalez-Gugel 9, Andrew X Zhu 10 11
|
|
| |
|
|
| |
| 141. | The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis |
| |
Hepatol Commun. 2022 May;6(5):1213-1226. doi: 10.1002/hep4.1886.Epub 2021 Dec 27.
Hamish Innes 1 2 3, Hans Dieter Nischalke 4, Indra Neil Guha 5, Karl Heinz Weiss 6, Will Irving 5, Daniel Gotthardt 7, Eleanor Barnes 8, Janett Fischer 9, M Azim Ansari 8, Jonas Rosendahl 10, Shang-Kuan Lin 8, Astrid Marot 11 12, Vincent Pedergnana 13, Markus Casper 14, Jennifer Benselin 5, Frank Lammert 14, John McLauchlan 15, Philip L Lutz 4, Victoria Hamill 1 3, Sebastian Mueller 16 17, Joanne R Morling 2 5, Georg Semmler 18 19, Florian Eyer 20, Johann von Felden 21, Alexander Link 22, Arndt Vogel 23, Jens U Marquardt 24, Stefan Sulk 25, Jonel Trebicka 26 27, Luca Valenti 28 29, Christian Datz 19, Thomas Reiberger 18, Clemens Schafmayer 30, Thomas Berg 9, Pierre Deltenre # 11 31 32, Jochen Hampe # 25 33, Felix Stickel # 34, Stephan Buch # 25
|
|
| |
| 142. | Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis |
| |
J Gastrointest Cancer. 2022 May 30
Gauri Mishra 1 2, Ammar Majeed 3 4, Anouk Dev 5 3, Guy D Eslick 6, David J Pinato 7, Hirofumi Izumoto, Atsushi Hiraoka 8, Teh-Ia Huo 9 10, Po-Hong Liu 11, Philip J Johnson 12, Stuart K Roberts 3 4
|
|
| |
| 143. | Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis |
| |
Neoplasia. 2022 Aug;30:100809. doi: 10.1016/j.neo.2022.100809.Epub 2022 May 27.
Fausto Petrelli 1, Michele Manara 2, Silvia Colombo 3, Gabriella De Santi 2, Michele Ghidini 4, Marco Mariani 2, Alessandro Iaculli 5, Emanuele Rausa 6, Valentina Rampulla 2, Marcella Arru 2, Matteo Viti 2, Veronica Lonati 7, Antonio Ghidini 8, Andrea Luciani 7, Antonio Facciorusso 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 150. | Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib |
| |
Eur J Cancer. 2022 May;167:1-12. doi: 10.1016/j.ejca.2022.02.009.Epub 2022 Mar 29.
Masatoshi Kudo 1, Richard S Finn 2, Julien Edeline 3, Stéphane Cattan 4, Sadahisa Ogasawara 5, Daniel H Palmer 6, Chris Verslype 7, Vittorina Zagonel 8, Laetitia Fartoux 9, Arndt Vogel 10, Debashis Sarker 11, Gontran Verset 12, Stephen L Chan 13, Jennifer Knox 14, Bruno Daniele 15, Thomas Yau 16, Ellen B Gurary 17, Abby B Siegel 18, Anran Wang 19, Ann-Lii Cheng 20, Andrew X Zhu 21, KEYNOTE-224 Investigators
|
|
| |
|
|
| |
|
|
| |
| 153. | BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update |
| |
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018.Epub 2021 Nov 19.
Maria Reig 1, Alejandro Forner 2, Jordi Rimola 3, Joana Ferrer-Fàbrega 4, Marta Burrel 5, Ángeles Garcia-Criado 3, Robin K Kelley 6, Peter R Galle 7, Vincenzo Mazzaferro 8, Riad Salem 9, Bruno Sangro 10, Amit G Singal 11, Arndt Vogel 12, Josep Fuster 13, Carmen Ayuso 14, Jordi Bruix 15
|
|
| |
| 154. | Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial |
| |
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):208-218.doi: 10.1016/S2468-1253(21)00427-1. Epub 2022 Jan 20.
Ahmed Omar Kaseb 1, Elshad Hasanov 2, Hop Sanderson Tran Cao 3, Lianchun Xiao 4, Jean-Nicolas Vauthey 3, Sunyoung S Lee 5, Betul Gok Yavuz 5, Yehia I Mohamed 5, Aliya Qayyum 6, Sonali Jindal 7, Fei Duan 7, Sreyashi Basu 7, Shalini S Yadav 7, Courtney Nicholas 7, Jing Jing Sun 7, Kanwal Pratap Singh Raghav 5, Asif Rashid 8, Kristen Carter 5, Yun Shin Chun 3, Ching-Wei David Tzeng 3, Divya Sakamuri 5, Li Xu 5, Ryan Sun 4, Vittorio Cristini 9, Laura Beretta 10, James C Yao 5, Robert A Wolff 5, James Patrick Allison 11, Padmanee Sharma 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 160. | Nivolumab versus sorafenib in advanced hepatocellular carcinoma |
| |
Lancet Oncol. 2022 Jan;23(1):77-90. doi: 10.1016/S1470-2045(21)00604-5.Epub 2021 Dec 13.
(CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Thomas Yau 1, Joong-Won Park 2, Richard S Finn 3, Ann-Lii Cheng 4, Philippe Mathurin 5, Julien Edeline 6, Masatoshi Kudo 7, James J Harding 8, Philippe Merle 9, Olivier Rosmorduc 10, Lucjan Wyrwicz 11, Eckart Schott 12, Su Pin Choo 13, Robin Kate Kelley 14, Wolfgang Sieghart 15, Eric Assenat 16, Renata Zaucha 17, Junji Furuse 18, Ghassan K Abou-Alfa 8, Anthony B El-Khoueiry 19, Ignacio Melero 20, Damir Begic 21, Gong Chen 21, Jaclyn Neely 21, Tami Wisniewski 21, Marina Tschaika 21, Bruno Sangro 22
|
|
| |
| 161. | Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis |
| |
Gut. 2022 Mar;71(3):593-604. doi: 10.1136/gutjnl-2020-323663.Epub 2021 Mar 19.
Victor Sapena # 1, Marco Enea # 2, Ferran Torres # 3 4, Ciro Celsa # 2 5, Jose Rios 3 4, Giacomo Emanuele Maria Rizzo 2, Pierre Nahon 6, Zoe Mariño 7, Ryosuke Tateishi 8, Tatsuya Minami 8, Angelo Sangiovanni 9 10, Xavier Forns 7, Hidenori Toyoda 11, Stefano Brillanti 12, Fabio Conti 12, Elisabetta Degasperi 9 10, Ming-Lung Yu 13 14, Pei-Chien Tsai 13, Kevin Jean 15 16, Mohamed El Kassas 17, Hend Ibrahim Shousha 18, Ashraf Omar 18, Claudio Zavaglia 19, Hiroko Nagata 20, Mina Nakagawa 21 22, Yasuhiro Asahina 23, Amit G Singal 24, Caitlin Murphy 24, Mohamed Kohla 25, Chiara Masetti 26, Jean-François Dufour 27 28, Nicolas Merchante 29, Luisa Cavalletto 30, Liliana Lc Chemello 30, Stanislas Pol 31, Javier Crespo 32 33, Jose Luis Calleja 34 35, Rosanna Villani 36, Gaetano Serviddio 36, Alberto Zanetto 37, Sarah Shalaby 37, Francesco Paolo Russo 37, Rob Bielen 38 39, Franco Trevisani 40, Calogero Cammà 2, Jordi Bruix 1, Giuseppe Cabibbo 41, Maria Reig 42
|
|
| |
| 162. | Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial |
| |
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):219-229.doi: 10.1016/S2468-1253(21)00385-X. Epub 2022 Jan 20.
Thomas U Marron 1, Maria Isabel Fiel 2, Pauline Hamon 3, Nathalie Fiaschi 4, Edward Kim 5, Stephen C Ward 2, Zhen Zhao 6, Joel Kim 3, Paul Kennedy 7, Ganesh Gunasekaran 8, Parissa Tabrizian 8, Deborah Doroshow 9, Meredith Legg 9, Ashley Hammad 9, Assaf Magen 3, Alice O Kamphorst 10, Muhammed Shareef 11, Namita T Gupta 4, Raquel Deering 4, Wei Wang 4, Fang Wang 4, Pradeep Thanigaimani 4, Jayakumar Mani 4, Leanna Troncoso 3, Alexandra Tabachnikova 3, Christie Chang 3, Guray Akturk 12, Mark Buckup 3, Steven Hamel 12, Giorgio Ioannou 12, Clotilde Hennequin 3, Hajra Jamal 3, Haley Brown 3, Antoinette Bonaccorso 13, Daniel Labow 8, Umut Sarpel 8, Talia Rosenbloom 14, Max W Sung 15, Baijun Kou 4, Siyu Li 4, Vladimir Jankovic 4, Nicola James 4, Sara C Hamon 4, Hung Kam Cheung 4, Jennifer S Sims 4, Elizabeth Miller 4, Nina Bhardwaj 16, Gavin Thurston 4, Israel Lowy 4, Sacha Gnjatic 17, Bachir Taouli 18, Myron E Schwartz 19, Miriam Merad 20
|
|
| |
| 163. | . Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma |
| |
J Hepatol. 2022 Apr;76(4):862-873.doi: 10.1016/j.jhep.2021.11.030. Epub 2021 Dec 11
Ann-Lii Cheng 1, Shukui Qin 2, Masafumi Ikeda 3, Peter R Galle 4, Michel Ducreux 5, Tae-You Kim 6, Ho Yeong Lim 7, Masatoshi Kudo 8, Valeriy Breder 9, Philippe Merle 10, Ahmed O Kaseb 11, Daneng Li 12, Wendy Verret 13, Ning Ma 14, Alan Nicholas 15, Yifan Wang 16, Lindong Li 17, Andrew X Zhu 18, Richard S Finn 19
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 169. | Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma |
| |
Cancers (Basel). 2022 Mar 23;14(7):1634. doi: 10.3390/cancers14071634.
Gael S Roth 1 2 3, Olivier Hernandez 2, Najeh Daabek 4 5, Bleuenn Brusset 2, Yann Teyssier 1 6, Julien Ghelfi 1 3 6, Marie Noelle Hilleret 2, Christian Sengel 6, Ivan Bricault 1 6, Thomas Decaens 1 2 3, Charlotte Costentin 1 2 3
|
|
| |
|
|
| |
|
|
| |
| 172. | Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience |
| |
Ther Adv Med Oncol. 2022 Feb 26;14:17588359221080298. doi: 10.1177/17588359221080298.eCollection 2022.
Tiago de Castro 1, Leonie S Jochheim 2, Melanie Bathon 1, Sabrina Welland 1, Bernhard Scheiner 3, Kateryna Shmanko 4, Daniel Roessler 5, Najib Ben Khaled 5, Matthias Jeschke 2, Johannes M Ludwig 6, Jens U Marquardt 7, Arndt Weinmann 4, Matthias Pinter 3, Christian M Lange 2, Arndt Vogel 8, Anna Saborowski 1
|
|
| |
| 173. | Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma |
| |
J Hepatol. 2021 Dec;75(6):1387-1396. doi: 10.1016/j.jhep.2021.07.037.Epub 2021 Aug 27.
Jens Ricke 1, Regina Schinner 2, Max Seidensticker 2, Antonio Gasbarrini 3, Otto M van Delden 4, Holger Amthauer 5, Bora Peynircioglu 6, Irene Bargellini 7, Roberto Iezzi 8, Enrico N De Toni 9, Peter Malfertheiner 10, Maciej Pech 11, Bruno Sangro 12
|
|
| |
|
|
| |
| 175. | Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression |
| |
Clin Gastroenterol Hepatol. 2022 Feb;20(2):283-292.e10.doi: 10.1016/j.cgh.2021.05.002. Epub 2021 May 28.
Lorenzo A Orci 1, Marco Sanduzzi-Zamparelli 2, Berta Caballol 3, Victor Sapena 3, Nicola Colucci 4, Ferran Torres 5, Jordi Bruix 3, María Reig 6, Christian Toso 7
|
|
| |
| 176. | Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade |
| |
Br J Cancer. 2022 Mar;126(4):569-575. doi: 10.1038/s41416-021-01532-5.Epub 2021 Oct 7.
Robin Kate Kelley # 1, Rebecca Miksad # 2 3 4, Irfan Cicin 5, YenHsun Chen 6, Heinz-Josef Klümpen 7, Stefano Kim 8, Zhong-Zhe Lin 9, Jillian Youkstetter 10, Saswati Hazra 10, Suvajit Sen 10, Ann-Lii Cheng 9, Anthony B El-Khoueiry 11, Tim Meyer 12, Ghassan K Abou-Alfa 13 14
|
|
| |
|
|
| |
| 178. | Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial |
| |
J Cancer Res Clin Oncol. 2022 Feb;148(2):475-485.doi: 10.1007/s00432-021-03627-1. Epub 2021 Apr 14.
Osman Öcal 1, Kerstin Schütte 2, Juozas Kupcinskas 3, Egidijus Morkunas 3, Gabija Jurkeviciute 3, Enrico N de Toni 4, Najib Ben Khaled 4, Thomas Berg 5, Peter Malfertheiner 4, Heinz Josef Klümpen 6, Christian Sengel 7, Bristi Basu 8, Juan W Valle 9, Julia Benckert 10, Antonio Gasbarrini 11, Daniel Palmer 12, Ricarda Seidensticker 1, Moritz Wildgruber 1, Bruno Sangro 13, Maciej Pech 14, Jens Ricke 1, Max Seidensticker 15
|
|
| |
|
|
| |
|
|
| |
| 181. | Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study |
| |
Hepatology. 2022 Mar 21. doi: 10.1002/hep.32468. Online ahead of print.
Antonio D'Alessio 1 2, Claudia Angela Maria Fulgenzi 1 3, Naoshi Nishida 4, Martin Schönlein 5, Johann von Felden 6, Kornelius Schulze 6, Henning Wege 6, Vincent E Gaillard 7, Anwaar Saeed 8, Brooke Wietharn 8, Hannah Hildebrand 8, Linda Wu 9, Celina Ang 9, Thomas U Marron 9, Arndt Weinmann 10, Peter R Galle 10, Dominik Bettinger 11, Bertram Bengsch 11 12 13, Arndt Vogel 14, Lorenz Balcar 15, Bernhard Scheiner 15, Pei-Chang Lee 16, Yi-Hsiang Huang 16 17, Suneetha Amara 18, Mahvish Muzaffar 18, Abdul Rafeh Naqash 18 19, Antonella Cammarota 2 20, Nicola Personeni 2 20, Tiziana Pressiani 20, Rohini Sharma 1, Matthias Pinter 15, Alessio Cortellini 1, Masatoshi Kudo 4, Lorenza Rimassa 2 20, David J Pinato 1 21
|
|
| |
| 182. | T cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma |
| |
J Hepatol. 2022 Mar 31;S0168-8278(22)00180-5. doi: 10.1016/j.jhep.2022.02.032.Online ahead of print.
Maryam Barsch 1, Henrike Salié 1, Alexandra Emilia Schlaak 1, Zhen Zhang 1, Moritz Hess 2, Lena Sophie Mayer 1, Catrin Tauber 1, Patricia Otto-Mora 1, Takuya Ohtani 3, Tobias Nilsson 1, Lara Wischer 1, Frances Winkler 1, Sasikant Manne 3, Andrew Rech 3, Annette Schmitt-Graeff 4, Peter Bronsert 4, Maike Hofmann 1, Christoph Neumann-Haefelin 1, Tobias Boettler 1, Stefan Fichtner-Feigl 5, Florian van Boemmel 6, Thomas Berg 6, Lorenza Rimassa 7, Luca Di Tommaso 8, Anwaar Saeed 9, Antonio D'Alessio 10, David J Pinato 11, Dominik Bettinger 1, Harald Binder 2, E John Wherry 3, Michael Schultheiss 1, Robert Thimme 1, Bertram Bengsch 12
|
|
| |
| 183. | The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group |
| |
HPB (Oxford). 2022 Jan 11;S1365-182X(22)00001-6. doi: 10.1016/j.hpb.2022.01.001.Online ahead of print.
Maurizio Iaria 1, Giorgio Bianchi 2, Federico Fazio 3, Francesco Ardito 4, Pasquale Perri 5, Nicholas Pontarolo 6, Simone Conci 7, Matteo Donadon 8, Matteo Zanello 9, Quirino Lai 10, Simone Famularo 11, Sarah Molfino 12, Ivano Sciannamea 13, Luca Fumagalli 14, Paola Germani 15, Antonio Floridi 16, Cecilia Ferrari 17, Giuseppe Zimmitti 18, Albert Troci 19, Mauro Zago 20, Valentina Ferraro 21, Federica Cipriani 22, Stefan Patauner 23, Giuliano La Barba 24, Maurizio Romano 25, Giacomo Zanus 25, Giorgio Ercolani 26, Antonio Frena 23, Luca Aldrighetti 22, Riccardo Memeo 21, Enrico Pinotti 27, Michele Crespi 19, Moh'd Abu Hilal 18, Guido Griseri 17, Paola Tarchi 15, Marco Chiarelli 14, Adelmo Antonucci 13, Gian L Baiocchi 12, Fabrizio Romano 28, Massimo Rossi 10, Elio Jovine 9, Guido Torzilli 8, Andrea Ruzzenente 7, Marcello Maestri 6, Gian L Grazi 5, Felice Giuliante 4, Alessandro Ferrero 3, Raffaele Dalla Valle 2, HE.RC.O.LE.S. GROUP
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| | | | |
